Insulet (PODD): Evaluating Valuation After Q3 2025 Results, Upgraded Guidance, and Omnipod Expansion [Yahoo! Finance]
Insulet Corporation (PODD)
Last insulet corporation earnings: 2/25 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.insulet.com/investor-relations
Company Research
Source: Yahoo! Finance
This outcome was due to meaningful expansion in its Omnipod insulin delivery system. Management boosted full-year guidance as business momentum remains strong. See our latest analysis for Insulet. Insulet's latest breakout results have built on a year of steadily improving sentiment, powering the stock to a 24.5% year-to-date share price return and a robust 19.3% total shareholder return over the past twelve months. Momentum has picked up further after recent strong guidance and European integration wins. This signals that investors are looking past short-term volatility and focusing on the company's long-term growth story. If you're interested in discovering more healthcare innovators making headlines, you can check out See the full list for free. With shares rallying and guidance continually raised, the question now is whether Insulet's relentless execution still leaves the stock undervalued, or if the market has already priced in the company's next phase of growth. Most P
Show less
Read more
Impact Snapshot
Event Time:
PODD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PODD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PODD alerts
High impacting Insulet Corporation news events
Weekly update
A roundup of the hottest topics
PODD
News
- Insulet (NASDAQ:PODD) had its "buy" rating reaffirmed by analysts at Cowen Inc.MarketBeat
- Insulet Announces FDA 510(k) Clearance of Omnipod® 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod ExperienceBusiness Wire
- Insulet: Excellent Business, Valuation Hurdle Remains [Seeking Alpha]Seeking Alpha
- Artisan International Small-Mid Fund Q3 2025 Contrarianism Pays Off [Seeking Alpha]Seeking Alpha
- How the Narrative Around Insulet Is Evolving After Investor Day and New Analyst Targets [Yahoo! Finance]Yahoo! Finance
PODD
Earnings
- 11/6/25 - Beat
PODD
Sec Filings
- 11/26/25 - Form 144
- 11/24/25 - Form 144
- 11/6/25 - Form 10-Q
- PODD's page on the SEC website